China Healthcare Weekly Wrap (5-9 Oct)
Key news this week: 1) Arrivent's ph3 lung cancer study flop, 2) efgartigimod (argenx/ZLAB) discontinued in a ph3 study in Sjogren’s disease, 3)...
83 Views
Primer: Zai Lab Ltd (ZLAB US) - May 2026
Zai Lab is a high-growth, commercial-stage biopharmaceutical company focused on bringing innovative medicines to the Greater China market...
122 Views
China Healthcare Weekly Wrap (17-21 Aug)
In this weekly wrap, we cover 1H26 results from Genscript, Hengrui, Sino Biopharm, CSPC, Kelun Biotech. Other news/updates include Zai Lab/Argenx,...
97 Views
China Healthcare Weekly Wrap (3-7 Aug)
Wuxi Apptec 2Q results beat; BeOne 2Q driven by robust Brukinsa; Innovent robust 2Q product revenue +13% QoQ; Alphamab licensed-out TROP2/HER3 ADC...
117 Views
China Healthcare Weekly Wrap (15-21 June)
Hengrui releases China phase 3 data for oral GLP-1 HRS7535 in T2D; Harbour/BioMap for AI- company MegaStream. Other updates: Legend, Everest,...
107 Views